SMAD1 and Miyoshi myopathy: Moreover, we showed that DM blocks SMAD1 phosphorylation(p-SMAD1), leading to diminished survival of MM cells, and that addition of DM to standard of MM therapy (BTZ) effectively kill drug-resistant MM in a pre-clinical model.